OMCL
Omnicell, Inc.
Health Information Services · Healthcare · United States
36.88
close · 2026-10-29
value
67
cheaper than peers67
quality
70
stronger fundamentals70
ranked against
Health Information Services
value
quality
27 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.30× | 83 |
| price to sales | 1.35× | 63 |
| forward P/E | 17.95× | 60 |
| EV to EBITDA | 18.83× | 45 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 5.9% | 72 |
| debt to equity | 15.5% | 65 |
| return on equity | 3.1% | 60 |
| revenue growth | 7.5% | 50 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $134.2M |
| employees | 3,485 |
| first trade | 2001-08-09 |
| next earnings | 2026-10-29 |
| fundamentals updated | 2026-10-29 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 0.04 | 0.27 | -0.45 | 0.12 |
| free cash flow | $69.4M | $134.9M | $126.1M | $17.0M |
| net income | $2.1M | $12.5M | -$20.4M | $5.6M |
| revenue | $1.18B | $1.11B | $1.15B | $1.30B |